SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

BIOCON

BSE: 532523 29 Jul 2025
Healthcare
₹ 390.2
Biocon Ltd. specializes in Pharmaceuticals within the Healthcare sector.

BIOCON - Share Price & Details

Market Cap
₹53,231
High /Low
406.0 / 291.0
Stock P/E
53.9
Book Value
₹180.0
Dividend Yield
0.13
ROCE
6.25
ROE
₹4.76
Face Value
5.0
PEG Ratio
5.14
EVEBITDA
₹15.2
Debt
18,362
CMP / FCF
55.2
Debt to equity
₹0.85
NP Ann
1,429
High price all time
488.0
Piotroski score
₹6.0
Graham Number
185.0
No. Eq. Shares
134.0
Net CF
₹2,004
Net profit
1,429
Price to book value
2.21
Interest Coverage
₹3.05
Low price all time
14.2
Industry PE
34.0
Reserves
₹21,044
Free Cash Flow
₹1,718

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,3.25-4.52NA-18.440
BIOCON LTD.7,065.00212.006,438.000.1853,23153.9
Laurus Labs Limited14542.71579.414327.52.934912397.0
Narayana Hrudayalaya Limited10,256.911,599.769,190.277.884074151.2

Peer Comparison Chart


About BIOCON

Biocon Ltd., with Security Code 532523, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Macro Trends and Their Impact on Biocon Limited (BIOCON) - Powerful growth strategies

(24 Jul 2025)
Macro Trends and Their Impact on Biocon Limited (BIOCON) ✌️【Growth Stocks】✌️ Expert-backed stock picks with real-time data and market trends...
Read more →

Biocon Biologics appoints Deepali Naair as Global Head - Brand & Corporate Communications

(24 Jul 2025)
Bengaluru: Biocon Biologics Limited, a fully integrated global biosimilars company and a subsidiary of Biocon Limited, has announced the...
Read more →

Biocon unit launches Entracept biosimilar in Australia, expands global footprint

(24 Jul 2025)
Biocon Biologics Ltd., a fully integrated global biosimilars company and a subsidiary of Biocon Ltd., announced the launch of Nepexto,...
Read more →

Biocon Biologics names Deepali Naair as Global Head Brand Corp Comm

(24 Jul 2025)
New Delhi, Jul 23 (PTI) Biocon Biologics on Wednesday announced the appointment of Deepali Naair as Global Head – Brand.
Read more →

Biocon Biologics launches Nepexto in Australia

(24 Jul 2025)
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced it has launched...
Read more →

Biocon Limited (532523) Signs Major Deal - Market-crushing profits

(23 Jul 2025)
Biocon Limited (532523) Signs Major Deal ✌️【Stock Analysis】✌️ Achieve investment success by combining expert insight, rigorous data analysis...
Read more →

Company Updates